Reneo Pharmaceuticals (RPHM)
US Market

Reneo Pharmaceuticals (RPHM) Financial Statements


Reneo Pharmaceuticals Financial Overview

Reneo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.373; its P/E ratio is -0.69; Reneo Pharmaceuticals is scheduled to report earnings on March 20, 2024, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -19.20M$ -19.53M$ -15.11M$ -13.60M$ -13.84M
EBITDA-$ -20.61M$ -15.72M$ -14.12M$ -13.82M
Net Income Common Stockholders$ -19.20M$ -19.50M$ -15.11M$ -13.60M$ -13.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 125.61M$ 142.68M$ 93.79M$ 101.17M$ 116.08M
Total Assets$ 130.39M$ 148.04M$ 98.29M$ 108.18M$ 122.50M
Total Debt$ 1.14M$ 1.22M$ 1.34M$ 1.46M$ 1.35M
Net Debt$ -124.48M$ -141.46M$ -92.44M$ -99.71M$ -114.73M
Total Liabilities$ 15.44M$ 15.51M$ 11.78M$ 8.21M$ 10.46M
Stockholders Equity$ 114.94M$ 132.53M$ 87.08M$ 99.97M$ 112.05M
Cash Flow-
Free Cash Flow-$ -16.12M$ -9.22M$ -15.86M$ -10.82M
Operating Cash Flow$ -18.77M$ -16.11M$ -9.05M$ -15.61M$ -10.79M
Investing Cash Flow$ 21.25M$ -69.01M$ 18.51M$ -26.92M$ -45.44M
Financing Cash Flow$ 173.00K$ 63.81M$ 1.01M$ 325.00K$ 97.00K
Currency in USD

Reneo Pharmaceuticals Earnings and Revenue History

Reneo Pharmaceuticals Debt to Assets

Reneo Pharmaceuticals Cash Flow

Reneo Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis